Stem cell therapy trial shows promise for regenerative treatment of heart failure

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

Debiopharm, SunRock sign agreement for cancer ADCs

The partnership will advance antibody drug conjugates for hard-to-treat cancers. Credit: Pawel Giovanni Cancemi/Shutterstock.com. Debiopharm and SunRock Biopharma have signed an exclusive option and licence

September 22, 2023

A centenarian thrives living alone, active and engaged

“The future is here,” the email announced. Hilda Jaffe, then 88, was letting her children know she planned to sell the family home in Verona,

December 10, 2024

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

Share this article J&J also acquired the remaining global rights for Nanobiotix’s radioenhancer oncology drug, NBTXR3, from LianBio. Image Credit: Michael Vi / Shutterstock. Johnson

December 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.